Evidence map›Paper›PMID 25239624›Full record

ArticleThe Journal of biological chemistry2014

Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies.

Francesco Pisani, Maria Grazia Mola, Laura Simone, Stefania Rosito, Domenico Alberga, Giuseppe Felice Mangiatordi, Gianluca Lattanzi, Orazio Nicolotti, Antonio Frigeri, Maria Svelto and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Francesco PisaniDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Maria Grazia MolaDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Laura SimoneDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Stefania RositoDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Domenico AlbergaDipartimento Interateneo di Fisica "M. Merlin", INFN and TIRES, Università di Bari "Aldo Moro", via Orabona, 4, 70126 Bari, Italy.
Giuseppe Felice MangiatordiDipartimento di Farmacia-Scienze del Farmaco, Via Orabona, 4, Università di Bari "Aldo Moro", Bari, 70126 Bari, and.
Gianluca LattanziDipartimento Interateneo di Fisica "M. Merlin", INFN and TIRES, Università di Bari "Aldo Moro", via Orabona, 4, 70126 Bari, Italy.
Orazio NicolottiDipartimento di Farmacia-Scienze del Farmaco, Via Orabona, 4, Università di Bari "Aldo Moro", Bari, 70126 Bari, and.
Antonio FrigeriDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Maria SveltoDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari.
Grazia Paola NicchiaDepartment of Bioscience, Biotechnologies and Biopharmaceutics and Center of Excellence in Comparative Genomics, University of Bari "Aldo Moro," 70126 Bari,. Electronic address: graziapaola.nicchia@uniba.it.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromyelitis optica (NMO) is characterized by the presence of pathogenic autoantibodies (NMO-IgGs) against supra-molecular assemblies of aquaporin-4 (AQP4), known as orthogonal array of particles (OAPs). NMO-IgGs have a polyclonal origin and recognize different conformational epitopes involving extracellular AQP4 loops A, C, and E. Here we hypothesize a pivotal role for AQP4 transmembrane regions (TMs) in epitope assembly. On the basis of multialignment analysis, mutagenesis, NMO-IgG binding, and cytotoxicity assay, we have disclosed the key role of aspartate 69 (Asp(69)) of TM2 for NMO-IgG epitope assembly. Mutation of Asp(69) to histidine severely impairs NMO-IgG binding for 85.7% of the NMO patient sera analyzed here. Although Blue Native-PAGE, total internal reflection fluorescence microscopy, and water transport assays indicate that the OAP Asp(69) mutant is similar in structure and function to the wild type, molecular dynamic simulations have revealed that the D(69)H mutation has the effect of altering the structural rearrangements of extracellular loop A. In conclusion, Asp(69) is crucial for the spatial control of loop A, the particular molecular conformation of which enables the assembly of NMO-IgG epitopes. These findings provide additional clues for new strategies for NMO treatment and a wealth of information to better approach NMO pathogenesis.

Indexed as

Amino Acid SequenceAnimalsAquaporin 4AutoantibodiesBiological TransportEpitopesHeLa CellsHumansHydrogen-Ion ConcentrationImmunoglobulin GMolecular Dynamics SimulationMolecular Sequence DataMutation, MissenseNeuromyelitis OpticaPoint MutationProtein BindingAQP4 protein, humanAquaporin 4AutoantibodiesEpitopesImmunoglobulin GWaterAquaporinAquaporin-4AstrocyteAutoimmune DiseaseEpitope DeterminantEpitope MappingNeurodegenerative DiseaseNeuromyelitis OpticaNMO-IgGOrthogonal Array of Particles

Identifiers

PMID25239624
PMCPMC4215237
OpenAlexW2090263479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.